/
/
WG2🔬🧠 New Publication is Out! 🔬🧠

WG2🔬🧠 New Publication is Out! 🔬🧠

We’re thrilled to share the latest publication from our Working Group 2 (WG2) at IMMUPARKNET COST Action 21117! Entitled “Experimental Models to Study Immune Dysfunction in the Pathogenesis of Parkinson’s Disease,” this insightful work delves into innovative methodologies for assessing immune profiles in PD.

The manuscript, authored by Jasna Saponjic et al., presents comprehensive research on various models used to study PD, encompassing toxic-induced models, genetic models, and more. The collaborative effort of all named authors has resulted in a robust exploration of peripheral and central immunity in PD pathogenesis.

📝 Conceptualization and drafting were led by F. Marino and C. Comi, with contributions from all authors across different sections of the work. Particularly notable are the contributions of M. Dragic and M.Z. Jovanovic to toxic-induced models, N. Nikolovski and N.B. Muluk to immune profiles, and Y. Gürsoy-Özdemir to the glymphatic system and BBB alterations. Additionally, A. Canak, P. Ntavaroukas, and S. Papoutsopoulou provided valuable insights into tissue infiltration assessment models, while R. Mejías and Á. Fontán-Lozano delved into genetic, agrochemical, and cellular models of PD. K.E. Fladmark contributed with other models of PD, ensuring a comprehensive approach.

🌟 Importantly, this research received support from COST Action IMMUPARKNET (CA 21117), highlighting the significance of collaborative initiatives in advancing scientific knowledge.

🔍 Dive into the full article here: DOI link

📅 Submission received: 31 January 2024
📅 Revised: 25 March 2024
📅 Accepted: 26 March 2024
📅 Published: 14 April 2024

Let’s continue to unravel the complexities of Parkinson’s Disease together and pave the way for novel therapeutic strategies! 💡💪

IMMUPARKNET #ParkinsonsDisease #Immunology #Research #Collaboration #ScientificPublication

Share this post

Facebook
Twitter
LinkedIn
WhatsApp

Latest Updates

wpc2026_logo

IMMUPARKNET, the leading network dedicated to researching the role of immunity and neuroinflammation in Parkinson’s Disease, proudly announces the participation of its prominent members at...

IMG_1591

For more than 20 years, the Dopamine Meetings have provided a collaborative forum for scientists from diverse backgrounds to share their latest work and ideas....

ChatGPT Image 27 mag 2026, 10_24_30

📍 Faculty of Medicine, University of Coimbra (FMUC), Portugal📅 12–14 June 2026 We are pleased to present the final program of the 4th and final...

Seville, 9–10 April 2026 The second edition of the IMMUPARKNET Training School was held at the Instituto de Biomedicina de Sevilla (IBiS) in Seville, Spain,...

Article wordpress

A new study published in “The Lancet Neurology” investigates whether azathioprine, a common immunosuppressant, could represent a breakthrough in slowing the progression of Parkinson’s Disease...

ChatGPT Image 25 gen 2026, 03_00_53

We are pleased to announce that the fourth and final Annual Conference of the IMMUPARKNET Action will take place in Coimbra, Portugal, from 12 to...